Hamid Emamekhoo

Dr. Hamid Emamekhoo is a board-certified medical oncologist and faculty member in the Division of Hematology, Medical Oncology, and Palliative Care at the University of Wisconsin–Madison. He specializes in the treatment and research of genitourinary cancers, including cancers of the kidney, bladder, prostate, and testicles.

Dr. Emamekhoo received his medical degree from Shahid Beheshti University of Medical Sciences in Tehran, Iran. He completed a postdoctoral research fellowship at the University of California, San Francisco, where he focused on molecular and gene-targeting studies. His medical residency was completed at Good Samaritan Hospital in Cincinnati, Ohio, followed by a prestigious fellowship in Hematology/Oncology at the Cleveland Clinic in Cleveland, Ohio.

Dr. Emamekhoo has developed a strong clinical and research interest in genitourinary malignancies. His patient care is guided by the principles of precision oncology—tailoring treatments to individual genetic profiles and tumor biology. He is actively involved in the design and execution of clinical trials targeting:

• Kidney Cancer
• Bladder Cancer
• Prostate Cancer
• Testicular Cancer

As a clinical innovator, Dr. Emamekhoo is particularly focused on the application of immunotherapy and targeted therapies. He serves as principal investigator or co-investigator on multiple ongoing trials using these advanced therapeutic approaches in different stages of cancer.

• Postdoctoral Research in Gene Targeting – UCSF
• Clinical Trials in Immunotherapy and Chemotherapy
• Member of American Society of Clinical Oncology (ASCO)
• Member of American Association of Cancer Research (AACR)

Dr. Emamekhoo is committed to improving cancer outcomes through innovative therapies, evidence-based practice, and compassionate care. His patients benefit from both cutting-edge research and personalized medical guidance tailored to their unique clinical situations.